Comparing Jornay PM vs Qelbree
| Jornay PM (methylphenidate) | Qelbree (viloxazine) |
|
|---|
| Jornay PM (methylphenidate) | Qelbree (viloxazine) |
|
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for ADHD. Jornay PM may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for ADHD. Qelbree may also be used for purposes not listed in this medication guide. |
Related suggestions ADHD (Attention Deficit Hyperactivity Disorder)
|
|||||||||||||||
| More about Jornay PM (methylphenidate) | More about Qelbree (viloxazine) | ||||||||||||||||
| Ratings & Reviews | |||||||||||||||||
|
Jornay PM has an average rating of 9.3 out of 10 from a total of 18 ratings on Drugs.com. 83% of reviewers reported a positive effect, while 0% reported a negative effect. |
Qelbree has an average rating of 5.1 out of 10 from a total of 44 ratings on Drugs.com. 39% of reviewers reported a positive effect, while 45% reported a negative effect. |
||||||||||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||||||||||
|
View all Jornay PM side effects |
View all Qelbree side effects |
||||||||||||||||
| Drug Class | |||||||||||||||||
| Generic Availability | |||||||||||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||||||||||
View all Jornay PM prices |
View all Qelbree prices |
||||||||||||||||
| Dosage Forms | |||||||||||||||||
|
|
||||||||||||||||
| Brand Names | |||||||||||||||||
| Other methylphenidate brands include: Aptensio XR, Concerta, Cotempla XR-ODT, Daytrana, Metadate CD, Methylin, Methylin ER, QuilliChew ER, Quillivant XR, Relexxii, Ritalin, Ritalin LA View more |
N/A |
||||||||||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||||||||||
|
4 hours |
7.02 hours |
||||||||||||||||
| CSA Schedule 1 View glossary of CSA terms | |||||||||||||||||
|
High potential for abuse
Has a high potential for abuse. Has a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions. Abuse may lead to severe psychological or physical dependence. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
| Pregnancy Category | |||||||||||||||||
|
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
||||||||||||||||
| Drug Interactions | |||||||||||||||||
|
A total of 207 drugs are known to interact with Jornay PM:
|
A total of 283 drugs are known to interact with Qelbree:
|
||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||
| Disease Interactions | |||||||||||||||||
| First Approval Date | |||||||||||||||||
|
August 08, 2018 |
April 02, 2021 |
||||||||||||||||
| WADA Class View classifications | |||||||||||||||||
|
N/A |
|||||||||||||||||
| More Information | |||||||||||||||||
| Patient Resources | |||||||||||||||||
| Professional Resources | |||||||||||||||||
| Related Treatment Guide | |||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.